When a couple arrives at Metro IVF after three or more failed IVF cycles, they carry something that goes beyond medical history. They carry the accumulated weight of hope raised and crushed — multiple times. They carry the financial toll of treatments that did not work. They carry the physical memory of injections, retrievals, transfers, and two-week waits that ended in grief. And beneath all of it, they carry a question that their previous clinics have not answered adequately: why?
This article is about exactly how Dr. Ashish Soni and the team at Metro IVF answer that question — the specific, step-by-step evaluation process applied to every patient who arrives with three or more failed IVF cycles. It is not a general description of fertility investigation. It is a detailed account of the clinical methodology that has allowed Metro IVF to find answers — and produce outcomes — in cases that other clinics considered exhausted.
It is written for couples who have been through three cycles and are wondering whether trying again is hope or futility. The answer, in most cases, is neither. It is investigation — the right investigation, finally applied to the right questions.
Why Three Failed Cycles Is a Specific Clinical Threshold
Three failed IVF cycles represents a specific clinical threshold — not just an accumulation of misfortune, but a pattern that demands a fundamentally different approach from anything that has preceded it.
After one failed cycle, a repeat attempt with minor protocol modification is reasonable. After two failed cycles, a more thorough investigation is warranted — as the previous articles in this series have established. After three failed cycles with no satisfying explanation and no fundamental change in approach, repeating a fourth cycle at the same clinic with the same assumptions is not a medical strategy. It is a repetition of a failed experiment.
The clinical reality is this: when three carefully conducted IVF cycles have all failed, the probability that the failure is simply bad luck — that nothing is fundamentally wrong with the approach and that the fourth cycle will spontaneously succeed — is very low. The probability that there is a specific, identifiable, and in many cases correctable reason for the repeated failure is high. Finding that reason requires an investigation that is more systematic, more comprehensive, and more willing to question prior assumptions than anything the couple has typically received.
At Metro IVF, the arrival of a patient with three or more failed cycles triggers a specific evaluation protocol — one designed not to confirm what has already been assumed, but to question everything that has been assumed and find what has been missed.
The Starting Point: Reading the Complete History Before Anything Else
The Metro IVF evaluation of a patient with three or more failed cycles does not begin with a new test. It begins with reading — carefully, completely, and critically — everything that has already been done.
Dr. Soni reviews every document from every previous cycle before forming any clinical opinion about what may be causing the failure. This review covers the complete stimulation records from each cycle — the starting medications and doses, the monitoring ultrasound findings at each visit, the follicle sizes and numbers at trigger, the trigger medication and timing, and the egg retrieval outcomes including total eggs retrieved, mature eggs, and fertilization results. It covers the embryology reports — how many embryos developed, what grades were assigned on what days, how many reached blastocyst stage, and what happened to any frozen embryos. It covers the transfer records — which embryos were transferred, on what day, with what endometrial thickness and pattern, and whether PGT-A testing was performed. And it covers every investigation report — every semen analysis, every hormonal test, every ultrasound, every specialized test that was or was not performed.
This reading — which typically takes thirty to forty-five minutes of focused attention — is not a formality. It is a diagnostic exercise. As Dr. Soni reads through each cycle, he is building a picture of what happened and, equally importantly, what was assumed without being confirmed. He is identifying the questions that were never asked, the tests that were never run, and the clinical decisions that were made on the basis of protocol rather than on the basis of this specific patient's actual findings.
In the majority of cases, this reading alone reveals one or more specific gaps — a test that was never ordered, a finding that was noted but never followed up, a protocol that was used across all three cycles without modification despite failing twice. These gaps become the foundation of the investigation that follows.
The Comprehensive Re-Evaluation: What It Covers and Why
Following the history review, Dr. Soni conducts a comprehensive re-evaluation of both partners. This evaluation is structured but individualized — structured because certain assessments are appropriate for every patient with three or more failed cycles, and individualized because the specific findings of the history review determine which additional investigations are prioritized.
The Female Partner Evaluation
Full hormonal reassessment. Hormonal parameters change over time — and three or more IVF cycles, each involving significant ovarian stimulation, may have altered the hormonal landscape from what was present at the beginning of treatment. A complete hormonal profile — including FSH, LH, estradiol, AMH, prolactin, thyroid function including TSH and thyroid antibodies, and DHEA-S — is repeated at the time of the Metro IVF evaluation. AMH in particular is re-assessed, because it is the most important determinant of stimulation protocol design, and a value measured two years ago may not reflect the current ovarian reserve.
Thyroid function is assessed against fertility-specific target ranges rather than general laboratory normal ranges. A TSH that falls within the general normal range of the reporting laboratory — up to 4.5 or 5.0 mIU/L in many laboratories — may nonetheless be above the fertility-specific optimal level of 2.5 mIU/L. This distinction, which many clinics never make, is assessed explicitly at Metro IVF and, when relevant, results in a recommendation for thyroid medication adjustment before the next cycle.
Hysteroscopy — if not recently performed. If hysteroscopy has not been performed within the preceding twelve months, or if it was performed but without the context of the current failure pattern, it is recommended as part of the Metro IVF evaluation. The uterine cavity is assessed directly — not by ultrasound estimation — for the presence of polyps, fibroids, adhesions, septum, or signs of chronic endometritis. In a significant proportion of patients presenting with three or more failed cycles, hysteroscopy reveals a uterine cavity abnormality that was present throughout the previous cycles and was not identified because hysteroscopy was never performed.
If hysteroscopy reveals an abnormality, it is corrected before any further transfer is attempted. This is not optional. Transferring another embryo into a uterus with an unaddressed structural abnormality is clinically unjustifiable — regardless of how good the embryo is.
Endometrial receptivity analysis — ERA. For patients with three or more failed transfers — particularly when the endometrium appeared adequate in thickness and pattern — ERA testing is strongly recommended. The ERA test, as previous articles in this series have described, determines the precise timing of the individual patient's implantation window by examining the gene expression pattern of endometrial tissue at the expected time of transfer.
In patients with three or more failed transfers, the probability of having a displaced implantation window — and therefore of having transferred embryos consistently at the wrong time — is substantially higher than in the general IVF population. ERA testing in this context is not an optional investigation. It is one of the most likely sources of a clinically actionable finding.
Immunological assessment. A comprehensive immunological work-up is included in the Metro IVF evaluation of every patient with three or more failed cycles. This includes antiphospholipid antibody testing — anticardiolipin antibodies and anti-beta-2 glycoprotein-1 antibodies — lupus anticoagulant, thyroid antibodies, and where clinically indicated, natural killer cell evaluation. Antiphospholipid syndrome — found in a meaningful proportion of women with recurrent implantation failure — is treatable with anticoagulation therapy, and its identification and treatment before the next cycle can produce a significant improvement in outcomes.
Thrombophilia screening. Inherited clotting disorders — including Factor V Leiden mutation, prothrombin gene mutation, protein C and protein S deficiency, and MTHFR polymorphisms — are assessed in patients with three or more failed cycles, particularly when prior losses have occurred or when placental blood flow compromise is clinically suspected. When thrombophilic conditions are identified, anticoagulation and antiplatelet therapy are incorporated into the next transfer preparation protocol.
Doppler assessment of uterine blood flow. The vascularity of the uterine lining — assessed through Doppler ultrasound measurement of uterine artery resistance and endometrial blood flow pattern — is evaluated as part of the endometrial preparation assessment. When blood flow resistance is found to be elevated, interventions to improve uterine perfusion — low-dose aspirin, vaginal sildenafil, vitamin E, pentoxifylline — are incorporated into the transfer preparation protocol for the next cycle.
Endometrial biopsy for chronic endometritis. An endometrial biopsy is performed for histological examination and culture to identify or exclude chronic endometritis — the low-grade inflammatory condition of the endometrial lining that silently prevents implantation in approximately 30 percent of women with recurrent implantation failure. When chronic endometritis is confirmed, targeted antibiotic therapy is completed before any further transfer is attempted.
Vitamin D and nutritional assessment. Vitamin D status is assessed through a serum 25-hydroxyvitamin D measurement. Deficiency — which is extremely prevalent in India — is corrected with supplementation before the next cycle. A nutritional assessment addressing CoQ10, folate, iron, and other factors relevant to endometrial and egg quality is conducted and supplementation recommendations are made based on the individual findings.
The Male Partner Evaluation
Sperm DNA fragmentation testing. This is performed for every male partner of a patient with three or more failed cycles — without exception and without regard to the results of previous standard semen analyses. The DFI is measured, and if elevated, the cause is investigated and a reduction strategy is implemented before the next cycle. As the previous article in this series established in detail, high sperm DNA fragmentation in a man with a normal standard semen analysis is one of the most consistently missed causes of repeated IVF failure and cannot be identified without this specific test.
Complete semen analysis with morphology assessment. Even if recent semen analyses have been performed, a fresh and thorough assessment — including detailed morphology examination using strict Kruger criteria rather than the more lenient WHO criteria — is conducted. Subtle morphological abnormalities that were within the threshold of older or less rigorous assessment may be identified when examined with strict criteria.
Scrotal Doppler ultrasound. A scrotal ultrasound is performed to assess for varicocele — the most common anatomical cause of elevated sperm DNA fragmentation. When varicocele is identified in a man with high DFI, surgical or radiological treatment is discussed and recommended where clinically appropriate.
Hormonal assessment. Where indicated by the semen findings — particularly in cases of low sperm count or poor morphology — a male hormonal profile including FSH, LH, testosterone, and prolactin is assessed. Hormonal abnormalities affecting spermatogenesis, when identified, are treated before the next cycle.
Reviewing and Redesigning the Protocol
The investigation described above is not performed in isolation from the clinical thinking about what comes next. As each finding is obtained, it informs the redesign of the protocol for the next cycle.
At Metro IVF, the stimulation protocol for a patient with three or more failed cycles is never a copy of the previous protocols. It is a completely new design — built from the current hormonal parameters, informed by the response patterns observed across the previous cycles, and adjusted based on whatever the current evaluation has revealed.
If AMH has changed since previous cycles, the stimulation dose is recalculated. If previous cycles showed excessive follicle recruitment with poor egg quality, a milder stimulation approach is considered. If previous cycles showed poor response with too few eggs retrieved, a more aggressive stimulation strategy or adjuncts such as growth hormone supplementation are evaluated. The protocol is not adjusted at the margins — it is rebuilt from the ground up.
Similarly, the endometrial preparation protocol for the next transfer is redesigned based on the endometrial findings from the current evaluation. If ERA has identified a displaced implantation window, the transfer timing is adjusted to the personalized window. If chronic endometritis has been treated, the transfer proceeds in a cycle following confirmed resolution. If Doppler has identified poor uterine blood flow, aspirin and sildenafil are incorporated. If thyroid function was suboptimal, the transfer proceeds only after TSH has been optimized.
This comprehensive redesign — of both the stimulation and transfer preparation protocols, based on individualized investigative findings — is the central clinical act that distinguishes the Metro IVF approach to three-or-more failed cycle patients from the approach of clinics that repeat the same protocol with minor adjustments.
The Conversation About Prognosis: Honest, Specific, and Complete
An essential component of the Metro IVF evaluation of three-or-more failed cycle patients is a frank, unhurried conversation about prognosis — what the evaluation findings suggest about the realistic chances of success with further treatment, and what the treatment options look like given those findings.
This conversation is not a motivational speech. It is not designed to encourage another cycle regardless of the clinical picture. It is an honest assessment of what the evaluation has found, what the identified factors suggest about the cause of previous failures, what the expected impact of addressing those factors is, and what a realistic picture of success probability looks like for this specific couple given their age, ovarian reserve, embryo history, and the findings of the current evaluation.
When the evaluation reveals specific, addressable causes of failure — and in most cases it does — the prognosis conversation includes a clear explanation of how addressing those causes changes the probability of success in the next cycle. When the evaluation does not reveal a clear cause — genuine unexplained recurrent failure, which is a real if less common finding — the prognosis conversation is equally honest about the uncertainty, and about what additional options exist beyond autologous IVF.
These options — which may include PGT-A testing of future embryos, donor egg IVF, donor embryo, or in the most severe cases gestational surrogacy — are discussed with the same clinical honesty that is applied to every other aspect of the evaluation. Dr. Soni does not recommend a fourth, fifth, or sixth autologous cycle when the clinical evidence suggests that a different path is more likely to result in the outcome the couple is seeking. And he does not withhold information about alternative options out of deference to what he thinks the couple wants to hear.
This honesty — which can be difficult to deliver and difficult to receive — is, in the clinical and human experience of Metro IVF, invariably what couples with three or more failed cycles need most. Not reassurance. Not optimism. Honest, complete, specific information about their situation — and the space to make truly informed decisions about what comes next.
What Couples with Three Failed Cycles Find at Metro IVF
The couples who come to Metro IVF after three or more failed cycles elsewhere share certain experiences when they describe what the evaluation process gave them.
The first is the experience of being fully read — of having a doctor who actually reviewed every cycle document, who asked specific questions about specific findings, and who demonstrated through the conversation that he understood their history in genuine detail rather than in summary.
The second is the experience of receiving a specific explanation — for the first time, in many cases — of what may have been causing their cycles to fail. Not a generic statement about implantation being unpredictable, but a specific finding: the ERA showed a displaced window. The sperm DNA fragmentation was 38 percent. The hysteroscopy found a polyp that was never detected on ultrasound. The antiphospholipid antibodies came back positive. These specific findings — which transform vague failure into identifiable cause — are described by virtually every patient who receives them as profoundly relieving, even when the finding is not good news.
The third is the experience of receiving a plan that is genuinely different — a protocol designed around what the evaluation actually found, rather than a variation of the approach that has already failed. A plan that makes sense, that is explained in full, and that the couple can understand and engage with rather than simply following instructions.
And in many cases — not all, but many — the fourth experience is the one that brought them to Metro IVF in the first place: the experience of the cycle that finally worked. The pregnancy that followed the evaluation that finally found what was missing.
Taking the Step
If you have had three or more failed IVF cycles and have not received the comprehensive evaluation described in this article — if the investigation has been incomplete, if the protocol has not fundamentally changed, if the explanation for failure has been inadequate — the evaluation that could change the direction of your treatment is available at Metro IVF in Ambikapur.
Bring every report from every cycle. Every stimulation record, every embryology report, every transfer record, every investigation result. The more complete the history you bring, the more productive the evaluation will be.
Dr. Soni will read all of it. He will find what was missed. He will tell you honestly what it means — for your prognosis, for your options, and for what the next step should be. And if there is a path forward that genuinely serves your interests — whether that path is another carefully redesigned autologous cycle, a different treatment approach, or an honest conversation about alternative options — he will describe it clearly, completely, and with the respect that every couple who has been through three failed cycles deserves.
Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist
Three failed IVF cycles deserves more than a fourth attempt with the same protocol. It deserves the evaluation that finally finds the answer. Book your consultation with Dr. Soni today.